| ashleyOneal | Дата: Пятница, 19.07.2013, 02:49 | Сообщение # 1 |
|
Лейтенант
Группа: Пользователи
Сообщений: 44
Статус: Offline
| In the area of sexual health, VIVUS completed phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, and avanafil is currently under review by the FDA. Tests for erection problems can help find a cause for a mans problem in having or maintaining an erection erectile dysfunction, or impotence. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors.
|
| |
|
|
